Cyclopharm Limited (CYC.AX)
AUD 1.2
(-0.42%)
AUD 1.2
(-0.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.19 Million | -6.66 Million | -1.62 Million | -8.93 Million | -489.34 Thousand | -1.1 Million |
| Net Income | -4.7 Million | -6.61 Million | -5.04 Million | -6.04 Million | -2.91 Million | -35.45 Thousand |
| Depreciation & Amortization | 938.83 Thousand | 931.48 Thousand | 758.73 Thousand | 910.29 Thousand | 999.93 Thousand | 510.22 Thousand |
| Deferred income taxes | -524.19 Thousand | -4.19 Million | 369.29 Thousand | 26.39 Thousand | -173.09 Thousand | 55.39 Thousand |
| Stock-based compensation | 524.19 Thousand | 648.2 Thousand | 756.58 Thousand | 795.6 Thousand | 378.36 Thousand | 37.96 Thousand |
| Change in working capital | -1.17 Million | -1.5 Million | 1.53 Million | -4.83 Million | 1.19 Million | -838.56 Thousand |
| Other non-cash items | -2.25 Million | 4.06 Million | -9168.00 | 211.56 Thousand | 24.01 Thousand | -836.9 Thousand |
| Investing Cash Flow | -508.46 Thousand | -1.54 Million | -1.16 Million | -874.19 Thousand | -820.49 Thousand | -1.4 Million |
| Investments in PPE | -537.99 Thousand | -1.54 Million | -1.16 Million | -530.98 Thousand | -477.28 Thousand | -206.09 Thousand |
| Acquisitions | 29.53 Thousand | - | - | -343.2 Thousand | -343.2 Thousand | -594.13 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 61.32 Thousand | -274.37 Thousand | -318.17 Thousand | -337.18 Thousand | -439.08 Thousand | -602.87 Thousand |
| Financing Cash Flow | -1.01 Million | -725.64 Thousand | 30.17 Million | -985.96 Thousand | 8.09 Million | -352.45 Thousand |
| Debt repayment | -276.42 Thousand | -289.42 Thousand | -288.7 Thousand | -289.75 Thousand | -610.21 Thousand | -54.28 Thousand |
| Dividends payments | -884.83 Thousand | -882.59 Thousand | -881.31 Thousand | -752.41 Thousand | -660.5 Thousand | -651.47 Thousand |
| Common Stock Repurchased | - | - | -1.65 Million | - | -413.03 Thousand | - |
| Common Stock Issuance | - | - | 31.34 Million | - | 9.36 Million | - |
| Other Financing Activities | -133.93 Thousand | 446.37 Thousand | 1.65 Million | 56.21 Thousand | 413.03 Thousand | 353.3 Thousand |
| Accounts receivables | -65.83 Thousand | 210.26 Thousand | 876.91 Thousand | -4.9 Million | 2.85 Million | -744.32 Thousand |
| Accounts payables | 931.88 Thousand | 890.13 Thousand | 1.44 Million | 2.12 Million | -1.3 Million | 1.17 Million |
| Inventory | -1.86 Million | -2.78 Million | -775.35 Thousand | -2.24 Million | 276.1 Thousand | -94.24 Thousand |
| Other working capital | -178.6 Thousand | 180.01 Thousand | -11.66 Thousand | 182.13 Thousand | -637.61 Thousand | -1.17 Million |
| Cash at beginning of period | 20.29 Million | 29.24 Million | 1.87 Million | 12.66 Million | 5.85 Million | 8.68 Million |
| Cash at end of period | 11.72 Million | 20.29 Million | 29.24 Million | 1.87 Million | 12.66 Million | 5.85 Million |
| Capital Expenditure | -537.99 Thousand | -1.54 Million | -1.16 Million | -530.98 Thousand | -477.28 Thousand | -206.09 Thousand |
| Effect of forex changes on cash | 155.11 Thousand | -14.55 Thousand | -6791.00 | 8982.00 | 23.94 Thousand | 28.18 Thousand |
| Net cash flow / Change in cash | -8.56 Million | -8.95 Million | 27.37 Million | -10.78 Million | 6.8 Million | -2.83 Million |
| Free Cash Flow | -7.73 Million | -8.21 Million | -2.79 Million | -9.46 Million | -966.62 Thousand | -1.31 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.5 Million | -1.8 Million | -4.7 Million | -2.89 Million | -6.61 Million | -4.04 Million |
| Depreciation & Amortization | 767.08 Thousand | 473.07 Thousand | 938.83 Thousand | 465.75 Thousand | 931.48 Thousand | 489.25 Thousand |
| Deferred income taxes | - | 463.44 Thousand | -524.19 Thousand | - | -4.19 Million | 1.74 Million |
| Stock-based compensation | - | 524.19 Thousand | 524.19 Thousand | - | 648.2 Thousand | 648.2 Thousand |
| Change in working capital | - | -1.93 Million | -1.17 Million | - | -1.5 Million | -2.62 Million |
| Other non-cash items | 1.9 Million | -3.52 Million | -2.25 Million | 1.96 Million | 4.06 Million | -1.19 Million |
| Investing Cash Flow | -433.47 Thousand | -242.96 Thousand | -508.46 Thousand | -265.5 Thousand | -1.54 Million | -183.87 Thousand |
| Investments in PPE | -433.47 Thousand | -304.89 Thousand | -537.99 Thousand | -233.1 Thousand | -1.54 Million | -183.87 Thousand |
| Acquisitions | - | 61.92 Thousand | 29.53 Thousand | -32.39 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -134.04 Thousand | 61.32 Thousand | -167.12 Thousand | -274.37 Thousand | -138.89 Thousand |
| Financing Cash Flow | 22.65 Million | -472.93 Thousand | -1.01 Million | -545.82 Thousand | -725.64 Thousand | -317.6 Thousand |
| Debt repayment | - | - | -276.42 Thousand | -141.34 Thousand | -289.42 Thousand | - |
| Dividends payments | - | -442.43 Thousand | -884.83 Thousand | -442.39 Thousand | -882.59 Thousand | -441.29 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 22.94 Million | - | - | - | - | - |
| Other Financing Activities | 5925.00 | 104.57 Thousand | -133.93 Thousand | 37.91 Thousand | 446.37 Thousand | 270 Thousand |
| Accounts receivables | - | -492.55 Thousand | -65.83 Thousand | - | 210.26 Thousand | -587.98 Thousand |
| Accounts payables | - | - | 931.88 Thousand | - | 890.13 Thousand | - |
| Inventory | - | -1.86 Million | -1.86 Million | - | -2.78 Million | -2.78 Million |
| Other working capital | - | 421.94 Thousand | -178.6 Thousand | - | 180.01 Thousand | 744.43 Thousand |
| Cash at beginning of period | 11.72 Million | 18.07 Million | 20.29 Million | 20.29 Million | 29.24 Million | 26.51 Million |
| Cash at end of period | 27.56 Million | 11.72 Million | 11.72 Million | 18.07 Million | 20.29 Million | 20.29 Million |
| Capital Expenditure | -433.47 Thousand | -304.89 Thousand | -537.99 Thousand | -233.1 Thousand | -1.54 Million | -183.87 Thousand |
| Effect of forex changes on cash | - | 166.44 Thousand | 155.11 Thousand | -11.33 Thousand | -14.55 Thousand | 7078.00 |
| Net cash flow / Change in cash | 15.83 Million | -6.35 Million | -8.56 Million | -2.21 Million | -8.95 Million | -6.22 Million |
| Free Cash Flow | -6.8 Million | -6.1 Million | -7.73 Million | -1.62 Million | -8.21 Million | -5.91 Million |
BAC-PM
PRN
7360
NAHARSPING
7841
PERI